Telehealth offers promising applications for cardiac disease diagnosis and management, particularly for remote populations, but requires further evidence from cost-effectiveness trials.
No takes yet. Share an insight, caveat, or question.
Supports cautious telehealth use for remote chronic cardiac care; leaves open cost-effectiveness confirmation in controlled trials.
Hooper et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: